Scientists have found that an old psychotic drug, fluphenazine reduces levels of metabolite associated with chronic pain signaling pathway A new study published in the journal Science on August 31, 2022, revealed how an already existing anti-psychotic drug is capable of blocking a signaling pathway associated with chronic neuropathic pain. According to the findings of this new stud... https://www.coherentmarketinsights.com/news/new-treatment-for-chronic-pain-may-come-from-old-anti-psychotic-drug-724